Governance

Clinical governance is a system through which NHS organisations are accountable for continuously improving the quality of their services and safeguarding high standards of care by creating an environment in which excellence in clinical care will flourish.

Clinical governance is an umbrella term. It covers activities that help sustain and improve high standards of patient care.
Health care organisations now have a duty to the communities they serve for maintaining the quality and safety of care. Whatever structures, systems and processes an organisation puts in place, it must be able to show evidence that standards are upheld.

 

Clinical Policies Operating Framework 

Outlines and explains the operating framework supporting Clinical Policies.

 

Joined Up Care Derbyshire: Consensus on Primary and Secondary Care Interface 

This document represents a strong set of clinically led principles to guide reviews of pathways which have a common architecture of good quality, patient- centred communication. Patient centred decision making ensures that actions taken are completed in a timely way, by the most appropriate individual or team and understood by all.

This document was created by Joined up Care Derbyshire Alliance for Clinical Transformation (ACT).

Defining the Boundaries between NHS and Private Healthcare

This policy defines the boundaries between privately funded and entitlement to NHS funding for patients under a range of circumstances. For more details please click on the link.

NICE Technology Appraisals (TAs)

NICE Technology Appraisals (TAs) are mandatory and as a principle the ICB does not produce separate policies or position statements for NICE TAs to which it is aligned e.g. NICE Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin Technology Appraisal Guidance [TA159] (Published: 22 October 2008)

Experimental and Unproven Treatments

Derby and Derbyshire ICB has deemed that treatments which are judged to be experimental or not of proven effectiveness, unless funded in the context of good quality studies will not be routinely funded.

For more information please see the Experimental and Unproven Treatments Policy. This policy should be used in conjunction with the Individual Funding Request Policy to assess Treatment Request Forms.